4DMedical Gains TGA Approval for CT:VQ Lung Imaging in Australia

Jun 29, 2026
4DMedical has received approval from the Australian Therapeutic Goods Administration for its CT:VQ imaging technology, enabling contrast-free ventilation and perfusion imaging using standard chest CT scans.

4DMedical has received approval from the Australian Therapeutic Goods Administration for its CT:VQ imaging technology, according to a press release. The company will introduce the software in Australia, enabling ventilation and perfusion imaging without the use of contrast agents.

CT:VQ generates ventilation and perfusion data directly from routine non-contrast chest CT scans. The technology provides a software-based option that integrates with existing CT infrastructure, expanding access to functional lung assessment.

The TGA approval follows CT:VQ’s clearance by the U.S. Food and Drug Administration in 2025, where it has been deployed in leading medical institutions.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.